Molecular Health GmbH

Molecular Health GmbH

Molecular Health GmbH

Molecular Health is an international biotech IT company based in Heidelberg, Germany, that has been developing innovative software in the areas of in silico and precision medicine since 2004. Molecular Health’s solutions make it possible to transform large amounts of data into evidence-based, medically relevant decision support. They are used where precision medical patient care or efficient drug development requires increasingly complex data interpretations. At Molecular Health, specialists from the fields of medicine, data science, biology and bioinformatics, and software development are working to make Big Data useful for healthcare. The result is intuitive analysis applications that are individually tailored to different healthcare requirements. Molecular Health is a portfolio company of dievini Hopp Biotech holding GmbH & Co. KG.

Company details

Kurfuersten-Anlage 21 , Heidelberg , 69115 Germany
View in map

Find locations served, office locations

Business Type:
Software vendor
Industry Type:
Pharmaceuticals
Market Focus:
Globally (various continents)

This company also provides solutions for other industrial applications.
Please, visit the following links for more info:

Image

Our Goals

We make knowledge usable. For physicians, patients, and companies.
The future of medicine is hybrid. Human discernment will continue to be essential for patient care and drug development in the coming decades. However, it will be increasingly supported by technical systems and artificial intelligence that can record, structure, and link the growing volume of medical information. A collaboration between humans and artificial intelligence applications is already leading medicine into one of the largest paradigm shifts, thanks in part to Molecular Health solutions.

We focus on patients.
Everything we do aims to improve patient care in the long term.

We deliver usable results.
Our solutions’ functionality and quality give our customers significant benefits.

We promote innovation.
By continuously integrating current health issues and patient needs into product development, we develop our solutions in a targeted way.

Our products and services are as diverse as our employees.
We know it takes people with different ideas, strengths, interests, and cultural backgrounds to make our company succeed, so we focus on diversity in our workforce and in our teams.

Molecular Health is a privately-held company funded by dievini Hopp Biotech holding GmbH & Co. KG, an investment holding of the founder and former CEO of SAP, Dietmar Hopp. Dievini Hopp BioTech invests in life sciences and healthcare companies, including CureVac based in Tübingen, Germany.

Investments focus on companies in precision medicine that are developing innovative therapeutic and diagnostic methods and have the potential to enable completely new forms of treatment.

The main indications are oncology, neurology, infectious diseases, cell therapy, and improved drug formulation. The geographic focus of Dievini Hopp BioTech’s investments is Germany and Europe. Companies are supported in setting up and implementing their global development and marketing.